Source:http://linkedlifedata.com/resource/lhgdn/association:38499
| Subject | Predicate | Object | Context |
|---|---|---|---|
| lhgdn:association:38499 | lhgdn:found_in | pubmed-article:15342390 | lld:lhgdn |
| lhgdn:association:38499 | lhgdn:geneRifSource | Results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity. | lld:lhgdn |
| lhgdn:association:38499 | lhgdn:mesh_code | D001943 | lld:lhgdn |
| lhgdn:association:38499 | lhgdn:associationIdType | http://http://linkedlifedat... | lld:lhgdn |
| lhgdn:association:38499 | lhgdn:umls_code | umls-concept:C1458155 | lld:mappings |
| entrez-gene:3091 | lhgdn:associationId | lhgdn:association:38499 | lld:lhgdn |